This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.
Report Includes
32 data tables and 39 additional tables
An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
A look at ESG trends
Information on developments in R&D, clinical trials, emerging technologies, and economic trends
Analysis of key companies’ market shares, proprietary technologies, patents, and alliances
Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA
Companies Mentioned
AGILENT TECHNOLOGIES INC. BIO-RAD LABORATORIES INC. BRUKER DANAHER CORP. MERCK KGAA SHIMADZU CORP. THERMO FISHER SCIENTIFIC INC. WATERS CORP.